TOP特許意匠商標
商標ウォッチ Twitter
公開日2025-04-16
公報種別公開国際商標公報
国際登録番号1838822
国際登録日2024-08-14
区分第5類(薬剤),第42類(科学・技術)
商品役務Pharmaceutical preparations for the prevention and treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; protein-based therapeutics for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; therapeutic and preventative vaccines; medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of diseases and disorders; RNA-based therapeutics; therapeutic agents for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders.,Research and development in the biotechnology field; consulting services in the fields of biotechnology and genetic science; development of new technology for others in the fields of genomics and biotechnology; providing laboratory research services in the field of gene expression or RNA-based therapeutics; testing, inspection, research, or development of chemical and biotechnology preparations; scientific research in the fields of pharmaceuticals全 34 件を表示, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids; providing information on the subject of scientific and medical research in the fields of biotechnology, biologics, biosimilars, pharmaceuticals, vaccines, and therapeutics related to genetic science, genomics, gene expression, protein-encoding nucleic acids or polypeptide-encoding nucleic acids.
基礎出願番号98597164
基礎出願日2024-06-12
基礎出願国US
出願人Orbital Therapeutics, Inc.
OCRテキストTHERAPEUTICS
OCRテキスト2
OCRについて
この商標をJ-PlatPatで参照する
Flag Counter

関連商標

Dyne Therapeutics, Inc.
26日前
NUTRASOURCE PHARMACEUTICAL AND NUTRACEUTICAL SERVICES INC.
13日前
CELLTRION, INC.
13日前
Incyte Holdings Corporation
QPARIKO
13日前
ADM Protexin Limited
13日前
BeiGene Switzerland GmbH
13日前
BEIJING INNO MEDICINE CO., LTD.
13日前
BEIJING INNO MEDICINE CO., LTD.
13日前
Shanghai Bao Pharmaceuticals Co.,Ltd.
13日前
Cascade Pharmaceuticals, Inc
13日前
KOREATECH Co., Ltd.
13日前
RecoVet GmbH
6日前
JION MEDITECH Co. Ltd
13日前
Amorepacific Corporation
13日前
Amorepacific Corporation
13日前
Amorepacific Corporation
13日前
NUTRASOURCE PHARMACEUTICAL AND NUTRACEUTICAL SERVICES INC.
13日前
PROVEPHARM LIFE SOLUTIONS
13日前
AstraZeneca AB
13日前
EXELTIS HEALTHCARE, S.L.
13日前
Harrow IP, LLC
13日前
Zero21 Holdings Limited
A-GAME
13日前
RecoVet GmbH
6日前
Clasp Therapeutics, Inc.
13日前
BAUSCH + LOMB IRELAND LIMITED
6日前
Amprion, Inc.
6日前
Biohaven Therapeutics Ltd.
6日前
SLA HEALTH INTERNATIONAL CO., LIMITED
6日前
Rgenta Therapeutics, Inc.
6日前
Orbital Therapeutics, Inc.
6日前
Glaxo Group Limited
6日前
Hangzhou Adlai Nortye Biopharma Co., Ltd.
6日前
個人
6日前
Gilead Sciences Ireland UC
6日前
Guangzhou LBP Medicine Science & Technology Co., Ltd.
6日前
EnduraVita B.V.
6日前
続きを見る